Last updated on September 11th, 2021 at 02:56 pm
A new discovery could lead to better treatments for multiple sclerosis (MS) and other autoimmune diseases, such as psoriasis and rheumatoid arthritis, researchers report.
MS occurs when immune cells get into the central nervous system (the brain and spinal cord), causing nerve damage that results in neurological problems.
However, the cause is unclear. Studies in a mouse model of MS – called experimental autoimmune encephalomyelitis (EAE) – have shown that immune T-cells, which secrete an immune molecule called IL-17, damage the myelin sheath surrounding nerves in the central nervous system (CNS).
Drugs that block IL-17 have shown promise in early clinical trials for treatment of relapsing-remitting MS. The drugs have already been licensed for treating psoriasis.
The push toward renewable energy in Africa helps the 570 million people who currently live without reliable power access. Many…
The Algerian government prepares the hosting facilities for the Intra-African Trade Fair 2025, which will open its doors on September…
South Africa captain Laura Wolvaardt wants cricket authorities to arrange more Test matches for women because Test cricket represents the…
The United States issued Ambassador Ebrahim Rasool a one-way travel ticket from South Africa to show decreasing trust between the…
Vida e Caffè achieved a major milestone when they opened their 300th South African outlet in Secunda Mpumalanga making it…
The Trade Promotion Organization of Iran revealed its plan to launch a special shipping line to West Africa through its…
This website uses cookies.